Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)
Drugs used to prevent SEIZURES or reduce their severity.
A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
Conditions characterized by disturbances of usual sleep patterns or behaviors. Sleep disorders may be divided into three major categories: DYSSOMNIAS (i.e. disorders characterized by insomnia or hypersomnia), PARASOMNIAS (abnormal sleep behaviors), and sleep disorders secondary to medical or psychiatric disorders. (From Thorpy, Sleep Disorders Medicine, 1994, p187)
A compound suggested to be both a nootropic and a neuroprotective agent.
The sodium salt of BENZOIC ACID. It is used as an antifungal preservative in pharmaceutical preparations and foods. It may also be used as a test for liver function.
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
Persistent and disabling ANXIETY.
Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered (simple partial seizure) or disturbed (complex partial seizure). Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely. (From Adams et al., Principles of Neurology, 6th ed, pp317)
Those disorders that have a disturbance in mood as their predominant feature.
Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; includes Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep.
Dibenzothiazepines are a class of heterocyclic chemical compounds that contain a dibenzothiazepine ring structure, which have been used in the development of various pharmaceutical drugs, particularly as tranquilizers, muscle relaxants, and anticonvulsants, but their use has declined due to side effects and the development of newer drugs.
A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.
Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.
Rough, noisy breathing during sleep, due to vibration of the uvula and soft palate.
Categorical classification of MENTAL DISORDERS based on criteria sets with defining features. It is produced by the American Psychiatric Association. (DSM-IV, page xxii)
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
A state in which there is an enhanced potential for sensitivity and an efficient responsiveness to external stimuli.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Simultaneous and continuous monitoring of several parameters during sleep to study normal and abnormal sleep. The study includes monitoring of brain waves, to assess sleep stages, and other physiological variables such as breathing, eye movements, and blood oxygen levels which exhibit a disrupted pattern with sleep disturbances.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
The state of being deprived of sleep under experimental conditions, due to life events, or from a wide variety of pathophysiologic causes such as medication effect, chronic illness, psychiatric illness, or sleep disorder.
Cyclohexanecarboxylic acids are organic compounds consisting of a cyclohexane ring substituted with a carboxylic acid group, typically represented by the structural formula C6H11COOH.
Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain.
Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
Dosage forms of a drug that act over a period of time by controlled-release processes or technology.
A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
The relationship between the dose of an administered drug and the response of the organism to the drug.
A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)
An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
Compounds capable of relieving pain without the loss of CONSCIOUSNESS.
A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event.
A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.
I'm sorry for any confusion, but the term "Argentina" is not a medical concept or condition that has a defined meaning within the medical field. Argentina is actually the second largest country in South America, and is known for its rich cultural history, diverse landscapes, and significant contributions to fields such as science, arts, and sports. If you have any questions related to healthcare, medicine, or biology, I would be happy to try to help answer those!
Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.
Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
The most common inhibitory neurotransmitter in the central nervous system.
Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Disorders related to substance abuse.
Elements of limited time intervals, contributing to particular results or situations.
Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.
The giving of drugs, chemicals, or other substances by mouth.
A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviors include aggressive conduct that causes or threatens physical harm to other people or animals, nonaggressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18. (From DSM-IV, 1994)
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany another another condition. (From DSM-IV, 1994)
Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.
A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by a another medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Therapy with two or more separate preparations given for a combined effect.
Disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Disorders related to or resulting from abuse or mis-use of alcohol.
Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Eastward long distance flights, sleep and wake patterns in air crews in connection with a two-day layover. (1/456)

The present study describes the spontaneous sleep/wake pattern in connection with an eastward (Stockholm to Tokyo, +8 h) transmeridian flight and short (51 h) layovers. To describe all sleep episodes and the recovery process across 4 days, and to relate adjustment to individual differences, 49 Scandinavian Airlines System (SAS) air crew were monitored for 9 days with activity monitors and sleep/wake diary before-during-after flight. The outbound flight involved a period of wakefulness extended to 21 h, frequently (87% of air crew) terminated by a long nap in Tokyo which was calm but difficult to wake up from. Then followed two night oriented sleep periods of normal length but of reduced efficiency, containing many and long awakenings. Napping was common during the extended periods of wakefulness, particularly during flights. During the recovery days, ease of rising from sleep in the mornings was difficult throughout, and feelings of not being refreshed returned to baseline levels on the third recovery sleep. Elevated daytime sleepiness (24% of the day) was observed on the first recovery day. No individual differences related to gender, age or position (cabin/pilot) was found in sleep strategy. Poor adjusters, subjects with a perceived lowered capacity on recovery days, showed more premature awakenings abroad and less refreshing sleep during the last 12 months, suggesting a decreased ability to cope with air crew scheduling. Comparisons with a westbound flight showed the eastbound flight layover sleep to be more problematic and containing more napping.  (+info)

Interface of epilepsy and sleep disorders. (2/456)

Obstructive sleep apnoea was first brought to prominence by Henri Gastaut, a French epileptologist. Since that time the interface between epilepsy and sleep disorders has received less attention than might be justified, recognizing that sleep deprivation is a poignant provocateur for seizures. Sleep deprivation is often used as a diagnostic procedure during electroencephalography (EEG) when waking EEG has failed to demonstrate abnormality. Patients referred to an outpatient neurological clinic for evaluation of possible seizures in whom sleep disorder was suspected, either due to snoring during the EEG or based on history, were evaluated with all-night diagnostic polysomnography (PSG) and appropriate intervention administered as indicated. Patient and seizure demography, sleep disorder and response to therapy were reviewed and the interface explored. Fifty patients aged between 10 and 83 years underwent PSG. Approximately half were diagnosed with epilepsy and almost three-quarters had sleep disorders sufficiently intrusive to require therapy (either continuous positive air pressure (CPAP) or medication). With co-existence of epilepsy and sleep disorders, proper management of sleep disorders provided significant benefit for seizure control. Snoring during EEG recordings could alert to the possibility of a sleep disorder even with epilepsy diagnosed. Where both epilepsy and sleep disorder coexist appropriate management of the sleep disorder improves control of the epilepsy.  (+info)

The effects of sleep inertia on decision-making performance. (3/456)

Sleep inertia, the performance impairment that occurs immediately after awakening, has not been studied previously in relation to decision-making performance. Twelve subjects were monitored in the sleep laboratory for one night and twice awoken by a fire alarm (slow wave sleep, SWS and REM sleep). Decision making was measured over 10 3-min trials using the 'Fire Chief' computer task under conditions of baseline. SWS and REM arousal. The most important finding was that sleep inertia reduces decision-making performance for at least 30 min with the greatest impairments (in terms of both performance and subjective ratings) being found within 3 min after abrupt nocturnal awakening. Decision-making performance was as little as 51% of optimum (i.e. baseline) during these first few minutes. However, after 30 min. performance may still be as much as 20% below optimum. The initial effects of sleep inertia during the first 9 min are significantly greater after SWS arousal than after REM arousal, but this difference is not sustained. Decision-making performance after REM arousal showed more variability than after SWS arousal. Subjects reported being significantly sleepier and less clear-headed following both SWS and REM awakenings compared with baseline and this was sustained across the full 30 min. In order to generalize this finding to real-life situations, further research is required on the effects of continuous noise, emotional arousal and physical activity on the severity and duration of sleep inertia.  (+info)

Bright light treatment used for adaptation to night work and re-adaptation back to day life. A field study at an oil platform in the North Sea. (4/456)

Night workers complain of sleepiness, reduced performance and disturbed sleep due to lack of adjustment of the circadian rhythm. In simulated night-work experiments scheduled exposure to bright light has been shown to reduce these complaints. Here we studied the effects of bright light treatment on the adaptation to 14 days of consecutive night work at an oil platform in the North Sea, and the subsequent readaptation to day life at home, using the Karolinska sleep/wake diary. Bright light treatment of 30 min per exposure was applied during the first 4 nights of the night-shift period and the first 4 days at home following the shift period. The bright light exposure was scheduled individually to phase delay the circadian rhythm. Bright light treatment modestly facilitated the subjective adaptation to night work, but the positive effect of bright light was especially pronounced during the re-adaptation back to day life following the return home. Sleepiness was reduced and the quality of day was rated better after exposure to bright light. The modest effect of bright light at the platform was, possibly, related to the finding that the workers seemed to adapt to night work within a few days even without bright light. These results suggest that short-term bright light treatment may help the adaptation to an extended night-work period, and especially the subsequent re-adaptation to day life.  (+info)

Periodic breathing during sleep in patients affected by fibromyalgia syndrome. (5/456)

Seventeen patients affected by fibromyalgia syndrome (FMS) (16 females and one male) and 17 matched healthy subjects underwent formal polysomnography, a sleep questionnaire and lung function tests. FMS patients slept significantly less efficiently than the healthy controls (p<0.01), had a higher proportion of stage 1 sleep (mean+/-SD, 21+/-6% versus 11+/-4%; p<0.001), less slow wave sleep (p<0.01) and twice as many arousals per hour of sleep (p<0.001). The respiratory pattern of FMS patients showed a high occurrence of periodic breathing (PB) (15+/-8% of total sleep time) in 15/17 patients, versus 2/17 control subjects. The short length of apnoeas and hypopnoeas did not affect the apnoea/hypopnoea index (5.1+/-3.5 versus 3.2+/-1.6; NS), but FMS patients had a greater number of desaturations per hour of sleep (8+/-5 versus 3+/-3; p<0.01). Pulmonary volumes did not differ between the two groups, but FMS patients had a lower transfer factor of the lung for carbon monoxide (TL,CO (5.8+1 versus 7.7+1 mmol x min(-1) x kPa(-1); p=0.001). PB occurrence correlated with TL,CO (r=-0.62; p=0.01), number of desaturations (r=0.76, p=0.001) and carbon dioxide tension in arterial blood (Pa,CO2) (r=-0.50; p=0.05). Stepwise multiple linear regression analysis showed desaturation frequency (p=0.0001) and TL,CO (p=0.029) to be the best predictors of PB percentage (R2 0.73; p=0.0001). Patients complaining of daytime hypersomnolence had a higher number of tender points, about twice as many arousals per hour and a lower sleep efficiency than patients who did not report this symptom. TL,CO was more impaired and the occurrence of PB was higher. The occurrence of periodic breathing in fibromyalgia syndrome patients, which was previously unreported, and is shown to be linked to a reduction of transfer factor of the lung for carbon monoxide could play a major role in the symptoms of poor sleep of these patients.  (+info)

Hypersomnia following uvulopalatopharyngoplasty for snoring. (6/456)

This report describes three cases who underwent uvulopalatopharyngoplasty for severe snoring and who subsequently developed progressive excessive daytime sleepiness. All three cases were shown to have sleep fragmentation as a result of non-apnoeic episodic upper airway narrowing. These cases raise the possibility that increased upper airway resistance during sleep may be exacerbated or even caused by uvulopalatopharyngoplasty. Ideally, sleep-disordered breathing should be carefully excluded before this surgery is offered as treatment for severe snoring.  (+info)

Snoring and excessive daytime somnolence among Polish middle-aged adults. (7/456)

There is considerable interest in the association of snoring and health consequences that have been linked to more severe sleep-disordered breathing, including obstructive sleep apnoea syndrome. The goal of this investigation was to assess the independent association of heavy, habitual snoring and daytime sleepiness. For this, a cross-sectional, population based study of snoring, sleepiness and other factors was conducted using the Warsaw sample of the Multinational Monitoring of Trends and Determinants of Cardiovascular Diseases (MONICA) study, a population-based multicentre study of cardiovascular disease. The well-defined MONICA sample of middle-aged males and females also allowed estimation of age- and sex-specific prevalences of habitual snoring in Polish adults. Data on self-reported snoring frequency and loudness, and daytime sleepiness using the Epworth Sleepiness Scale (ESS) and other questions, were collected with a postal questionnaire. Seventy-nine per cent of the MONICA sample completed the questionnaire, yielding a total of 1,186 participants. Of the total sample, 27% of the females and 48% of the males reported habitual snoring ("often" or "always"). There was an independent association of habitual snoring and excessive daytime sleepiness (EDS), sleepiness that interfered with work and with increasing ESS scores. Habitual snorers were 5.8 and 3.1 times more likely to report EDS in active and passive situations, respectively, compared to nonsnorers (all p<0.01). It is concluded that habitual snorers, most of whom are probably unlikely to have frank sleep apnoea syndrome, are at substantial risk for daytime sleepiness. These findings add support to the hypothesis that simple snoring is not benign and underscores the need for further research on health outcomes associated with this prevalent condition.  (+info)

Does sleep fragmentation impact recuperation? A review and reanalysis. (8/456)

Studies have shown that next-day performance and alertness are impaired by sleep fragmentation procedures even when total sleep time (TST) is unaffected. Based on these studies it has been hypothesized that both the duration and continuity of sleep determine its recuperative value. This review of the literature suggests that when sleep fragmentation procedures increase the relative amount of stage 1 sleep, next-day performance and alertness are impaired. Other studies suggest that stage 1 sleep has little or no recuperative value. Total sleep time, however, is typically defined as the sum of time spent in sleep stages 1, 2, 3, 4, and REM. In the present paper it is shown that when stage 1 sleep is excluded from TST, a stronger relationship between TST and subsequent alertness and performance emerges--and the need to invoke 'sleep continuity' as a variable that contributes independently to recuperative sleep processes is obviated. In the same way that partial or total sleep deprivation impairs alertness and performance, it is proposed that sleep disruption also impairs alertness and performance by reducing true recuperative sleep time.  (+info)

Disorders of excessive somnolence (DES) are a group of medical conditions characterized by an increased tendency to fall asleep or experience excessive daytime sleepiness (EDS), despite having adequate opportunity and circumstances for sleep. These disorders are typically classified as central disorders of hypersomnolence according to the International Classification of Sleep Disorders (ICSD-3).

The most common DES is narcolepsy, a chronic neurological disorder caused by the brain's inability to regulate sleep-wake cycles normally. Other DES include idiopathic hypersomnia, Kleine-Levin syndrome, and recurrent hypersomnia. These disorders can significantly impact an individual's daily functioning, quality of life, and overall health.

Narcolepsy is further divided into two types: narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). NT1 is characterized by the presence of cataplexy, a sudden loss of muscle tone triggered by strong emotions, while NT2 does not include cataplexy. Both types of narcolepsy involve excessive daytime sleepiness, sleep paralysis, hypnagogic/hypnopompic hallucinations, and fragmented nighttime sleep.

Idiopathic hypersomnia is a DES without the presence of REM-related symptoms like cataplexy or sleep paralysis. Individuals with idiopathic hypersomnia experience excessive daytime sleepiness and prolonged nighttime sleep, often lasting 10 to 14 hours, but do not feel refreshed upon waking.

Kleine-Levin syndrome is a rare DES characterized by recurrent episodes of excessive sleepiness, often accompanied by cognitive impairment, altered perception, hyperphagia (excessive eating), and hypersexuality during the episodes. These episodes can last days to weeks and typically occur multiple times per year.

Recurrent hypersomnia is another rare DES with recurring episodes of excessive sleepiness lasting for several days, followed by a period of normal or reduced sleepiness. The episodes are not as predictable or consistent as those seen in Kleine-Levin syndrome.

Treatment for DES typically involves pharmacological interventions to manage symptoms and improve daytime alertness. Modafinil, armodafinil, and traditional stimulants like amphetamine salts are commonly used to treat excessive daytime sleepiness. Additionally, antidepressants may be prescribed to manage REM-related symptoms like cataplexy or sleep paralysis. Non-pharmacological interventions, such as scheduled napping and good sleep hygiene practices, can also help improve symptoms.

Anticonvulsants are a class of drugs used primarily to treat seizure disorders, also known as epilepsy. These medications work by reducing the abnormal electrical activity in the brain that leads to seizures. In addition to their use in treating epilepsy, anticonvulsants are sometimes also prescribed for other conditions, such as neuropathic pain, bipolar disorder, and migraine headaches.

Anticonvulsants can work in different ways to reduce seizure activity. Some medications, such as phenytoin and carbamazepine, work by blocking sodium channels in the brain, which helps to stabilize nerve cell membranes and prevent excessive electrical activity. Other medications, such as valproic acid and gabapentin, increase the levels of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain, which has a calming effect on nerve cells and helps to reduce seizure activity.

While anticonvulsants are generally effective at reducing seizure frequency and severity, they can also have side effects, such as dizziness, drowsiness, and gastrointestinal symptoms. In some cases, these side effects may be managed by adjusting the dosage or switching to a different medication. It is important for individuals taking anticonvulsants to work closely with their healthcare provider to monitor their response to the medication and make any necessary adjustments.

Bipolar disorder, also known as manic-depressive illness, is a mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). When you become depressed, you may feel sad or hopeless and lose interest or pleasure in most activities. When your mood shifts to mania or hypomania (a less severe form of mania), you may feel euphoric, full of energy, or unusually irritable. These mood swings can significantly affect your job, school, relationships, and overall quality of life.

Bipolar disorder is typically characterized by the presence of one or more manic or hypomanic episodes, often accompanied by depressive episodes. The episodes may be separated by periods of normal mood, but in some cases, a person may experience rapid cycling between mania and depression.

There are several types of bipolar disorder, including:

* Bipolar I Disorder: This type is characterized by the occurrence of at least one manic episode, which may be preceded or followed by hypomanic or major depressive episodes.
* Bipolar II Disorder: This type involves the presence of at least one major depressive episode and at least one hypomanic episode, but no manic episodes.
* Cyclothymic Disorder: This type is characterized by numerous periods of hypomania and depression that are not severe enough to meet the criteria for a full manic or depressive episode.
* Other Specified and Unspecified Bipolar and Related Disorders: These categories include bipolar disorders that do not fit the criteria for any of the other types.

The exact cause of bipolar disorder is unknown, but it appears to be related to a combination of genetic, environmental, and neurochemical factors. Treatment typically involves a combination of medication, psychotherapy, and lifestyle changes to help manage symptoms and prevent relapses.

Sleep disorders are a group of conditions that affect the ability to sleep well on a regular basis. They can include problems with falling asleep, staying asleep, or waking up too early in the morning. These disorders can be caused by various factors such as stress, anxiety, depression, medical conditions, or substance abuse.

The American Academy of Sleep Medicine (AASM) recognizes over 80 distinct sleep disorders, which are categorized into the following major groups:

1. Insomnia - difficulty falling asleep or staying asleep.
2. Sleep-related breathing disorders - abnormal breathing during sleep such as obstructive sleep apnea.
3. Central disorders of hypersomnolence - excessive daytime sleepiness, including narcolepsy.
4. Circadian rhythm sleep-wake disorders - disruption of the internal body clock that regulates the sleep-wake cycle.
5. Parasomnias - abnormal behaviors during sleep such as sleepwalking or night terrors.
6. Sleep-related movement disorders - repetitive movements during sleep such as restless legs syndrome.
7. Isolated symptoms and normal variants - brief and occasional symptoms that do not warrant a specific diagnosis.

Sleep disorders can have significant impacts on an individual's quality of life, productivity, and overall health. If you suspect that you may have a sleep disorder, it is recommended to consult with a healthcare professional or a sleep specialist for proper evaluation and treatment.

Piracetam is a nootropic drug, which is primarily used in the treatment of cognitive disorders. It is a cyclic derivative of the neurotransmitter GABA (gamma-aminobutyric acid). Piracetam is believed to work by reducing the permeability of cell membranes in the brain, which may enhance communication between neurons and improve memory and learning.

Medically, piracetam is used off-label for a variety of conditions related to cognitive decline or impairment, such as Alzheimer's disease, dementia, and age-related cognitive decline. It has also been studied in the treatment of myoclonus (involuntary muscle jerks), dyslexia, and other neurological disorders.

It is important to note that while piracetam has shown some promise in improving cognitive function in certain populations, its effectiveness is still a subject of ongoing research and debate. Additionally, piracetam is not approved by the U.S. Food and Drug Administration (FDA) for any medical use, although it is available as a dietary supplement in the United States.

As with any medication or supplement, it's important to consult with a healthcare provider before taking piracetam to ensure that it is safe and appropriate for your individual needs.

Sodium benzoate is a chemical compound with the formula NaC7H5O2. It is a white crystalline powder that is readily soluble in water and alcohol. Sodium benzoate is a preservative commonly added to foods, beverages, and pharmaceuticals to inhibit microbial growth.

In medical terms, sodium benzoate may also be used as a medication to treat certain metabolic disorders such as hyperammonemia, which can occur in conditions like urea cycle disorders or liver disease. In these cases, sodium benzoate acts by binding with excess ammonia in the body and converting it into a compound that can be excreted through the kidneys.

It is important to note that people with a rare genetic disorder called benzoic aciduria should avoid foods or medications containing sodium benzoate, as they are unable to metabolize this compound properly.

A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.

Anxiety disorders are a category of mental health disorders characterized by feelings of excessive and persistent worry, fear, or anxiety that interfere with daily activities. They include several different types of disorders, such as:

1. Generalized Anxiety Disorder (GAD): This is characterized by chronic and exaggerated worry and tension, even when there is little or nothing to provoke it.
2. Panic Disorder: This is characterized by recurring unexpected panic attacks and fear of experiencing more panic attacks.
3. Social Anxiety Disorder (SAD): Also known as social phobia, this is characterized by excessive fear, anxiety, or avoidance of social situations due to feelings of embarrassment, self-consciousness, and concern about being judged or viewed negatively by others.
4. Phobias: These are intense, irrational fears of certain objects, places, or situations. When a person with a phobia encounters the object or situation they fear, they may experience panic attacks or other severe anxiety responses.
5. Agoraphobia: This is a fear of being in places where it may be difficult to escape or get help if one has a panic attack or other embarrassing or incapacitating symptoms.
6. Separation Anxiety Disorder (SAD): This is characterized by excessive anxiety about separation from home or from people to whom the individual has a strong emotional attachment (such as a parent, sibling, or partner).
7. Selective Mutism: This is a disorder where a child becomes mute in certain situations, such as at school, but can speak normally at home or with close family members.

These disorders are treatable with a combination of medication and psychotherapy (cognitive-behavioral therapy, exposure therapy). It's important to seek professional help if you suspect that you or someone you know may have an anxiety disorder.

Epilepsy, partial is a type of epilepsy characterized by recurrent, unprovoked seizures that originate in a specific, localized area of the brain. These seizures are also known as focal seizures and can vary in severity and symptoms depending on the location of the abnormal electrical activity in the brain.

Partial epilepsies can be further classified into two main categories: simple partial seizures and complex partial seizures. Simple partial seizures do not involve a loss of consciousness, while complex partial seizures are associated with impaired awareness or responsiveness during the seizure.

The causes of partial epilepsies can include brain injury, infection, stroke, tumors, genetic factors, or an unknown cause. Treatment typically involves anti-seizure medications, and in some cases, surgery may be recommended to remove the specific area of the brain responsible for the seizures.

Mood disorders are a category of mental health disorders characterized by significant and persistent changes in mood, affect, and emotional state. These disorders can cause disturbances in normal functioning and significantly impair an individual's ability to carry out their daily activities. The two primary types of mood disorders are depressive disorders (such as major depressive disorder or persistent depressive disorder) and bipolar disorders (which include bipolar I disorder, bipolar II disorder, and cyclothymic disorder).

Depressive disorders involve prolonged periods of low mood, sadness, hopelessness, and a lack of interest in activities. Individuals with these disorders may also experience changes in sleep patterns, appetite, energy levels, concentration, and self-esteem. In severe cases, they might have thoughts of death or suicide.

Bipolar disorders involve alternating episodes of mania (or hypomania) and depression. During a manic episode, individuals may feel extremely elated, energetic, or irritable, with racing thoughts, rapid speech, and impulsive behavior. They might engage in risky activities, have decreased sleep needs, and display poor judgment. In contrast, depressive episodes involve the same symptoms as depressive disorders.

Mood disorders can be caused by a combination of genetic, biological, environmental, and psychological factors. Proper diagnosis and treatment, which may include psychotherapy, medication, or a combination of both, are essential for managing these conditions and improving quality of life.

Sleep stages are distinct patterns of brain activity that occur during sleep, as measured by an electroencephalogram (EEG). They are part of the sleep cycle and are used to describe the different types of sleep that humans go through during a normal night's rest. The sleep cycle includes several repeating stages:

1. Stage 1 (N1): This is the lightest stage of sleep, where you transition from wakefulness to sleep. During this stage, muscle activity and brain waves begin to slow down.
2. Stage 2 (N2): In this stage, your heart rate slows, body temperature decreases, and eye movements stop. Brain wave activity becomes slower, with occasional bursts of electrical activity called sleep spindles.
3. Stage 3 (N3): Also known as deep non-REM sleep, this stage is characterized by slow delta waves. It is during this stage that the body undergoes restorative processes such as tissue repair, growth, and immune function enhancement.
4. REM (Rapid Eye Movement) sleep: This is the stage where dreaming typically occurs. Your eyes move rapidly beneath closed eyelids, heart rate and respiration become irregular, and brain wave activity increases to levels similar to wakefulness. REM sleep is important for memory consolidation and learning.

The sleep cycle progresses through these stages multiple times during the night, with REM sleep periods becoming longer towards morning. Understanding sleep stages is crucial in diagnosing and treating various sleep disorders.

Dibenzothiazepines are a class of heterocyclic chemical compounds that contain a dibenzothiazepine ring structure. This structure is composed of a benzene ring fused to a thiazepine ring, which is itself formed by the fusion of a benzene ring and a diazepine ring (a seven-membered ring containing two nitrogen atoms).

In the medical field, dibenzothiazepines are known for their pharmacological properties and have been used in the development of various drugs. Some dibenzothiazepine derivatives exhibit antipsychotic, anxiolytic, and anticonvulsant activities. However, due to their potential for adverse effects and the availability of safer alternatives, they are not widely used in clinical practice today.

It is important to note that specific dibenzothiazepine compounds may have unique properties and uses beyond their general classification as a chemical class. Always consult medical literature or healthcare professionals for accurate information on specific drugs or compounds.

Thalidomide is a pharmaceutical drug that was initially developed and marketed as a sedative and treatment for morning sickness in pregnant women. However, it was later found to cause severe birth defects when given during pregnancy, particularly damage to the limbs, ears, and eyes of the developing fetus. As a result, thalidomide was banned in many countries in the 1960s.

In recent years, thalidomide has been reintroduced as a treatment for certain medical conditions, including multiple myeloma (a type of cancer that affects plasma cells) and leprosy. It is also being studied as a potential treatment for other diseases, such as rheumatoid arthritis and Crohn's disease.

Thalidomide works by suppressing the immune system and inhibiting the formation of new blood vessels (angiogenesis). However, its use is tightly regulated due to its teratogenic effects, meaning it can cause birth defects if taken during pregnancy. Women who are pregnant or planning to become pregnant should not take thalidomide, and healthcare providers must follow strict guidelines when prescribing the drug to ensure that it is used safely and effectively.

Sleep is a complex physiological process characterized by altered consciousness, relatively inhibited sensory activity, reduced voluntary muscle activity, and decreased interaction with the environment. It's typically associated with specific stages that can be identified through electroencephalography (EEG) patterns. These stages include rapid eye movement (REM) sleep, associated with dreaming, and non-rapid eye movement (NREM) sleep, which is further divided into three stages.

Sleep serves a variety of functions, including restoration and strengthening of the immune system, support for growth and development in children and adolescents, consolidation of memory, learning, and emotional regulation. The lack of sufficient sleep or poor quality sleep can lead to significant health problems, such as obesity, diabetes, cardiovascular disease, and even cognitive decline.

The American Academy of Sleep Medicine (AASM) defines sleep as "a period of daily recurring natural rest during which consciousness is suspended and metabolic processes are reduced." However, it's important to note that the exact mechanisms and purposes of sleep are still being researched and debated among scientists.

Benzhydryl compounds are organic chemical compounds that contain the benzhydryl group, which is a functional group consisting of a diphenylmethane moiety. The benzhydryl group can be represented by the formula Ph2CH, where Ph represents the phenyl group (C6H5).

Benzhydryl compounds are characterized by their unique structure, which consists of two aromatic rings attached to a central carbon atom. This structure gives benzhydryl compounds unique chemical and physical properties, such as stability, rigidity, and high lipophilicity.

Benzhydryl compounds have various applications in organic synthesis, pharmaceuticals, and materials science. For example, they are used as building blocks in the synthesis of complex natural products, drugs, and functional materials. They also serve as useful intermediates in the preparation of other chemical compounds.

Some examples of benzhydryl compounds include diphenylmethane, benzphetamine, and diphenhydramine. These compounds have been widely used in medicine as stimulants, appetite suppressants, and antihistamines. However, some benzhydryl compounds have also been associated with potential health risks, such as liver toxicity and carcinogenicity, and their use should be carefully monitored and regulated.

Snoring is defined as the vibration of respiratory structures and the resulting sound, due to obstructed air movement during breathing while sleeping. It occurs when the tissues at the back of the throat relax and narrow during sleep, partially blocking the airway. The airflow causes these tissues to vibrate, leading to the snoring sound. Snoring can be a sign of various conditions such as obstructive sleep apnea or other respiratory disorders. It can also be influenced by factors such as alcohol consumption, obesity, and sleeping position.

The Diagnostic and Statistical Manual of Mental Disorders (DSM) is a publication of the American Psychiatric Association (APA) that provides diagnostic criteria for mental disorders. It is widely used by mental health professionals in the United States and around the world to diagnose and classify mental health conditions.

The DSM includes detailed descriptions of symptoms, clinical examples, and specific criteria for each disorder, which are intended to facilitate accurate diagnosis and improve communication among mental health professionals. The manual is regularly updated to reflect current research and clinical practice, with the most recent edition being the DSM-5, published in 2013.

It's important to note that while the DSM is a valuable tool for mental health professionals, it is not without controversy. Some critics argue that the manual medicalizes normal human experiences and that its categories may be too broad or overlapping. Nonetheless, it remains an essential resource for clinicians, researchers, and policymakers in the field of mental health.

The double-blind method is a study design commonly used in research, including clinical trials, to minimize bias and ensure the objectivity of results. In this approach, both the participants and the researchers are unaware of which group the participants are assigned to, whether it be the experimental group or the control group. This means that neither the participants nor the researchers know who is receiving a particular treatment or placebo, thus reducing the potential for bias in the evaluation of outcomes. The assignment of participants to groups is typically done by a third party not involved in the study, and the codes are only revealed after all data have been collected and analyzed.

Central nervous system (CNS) stimulants are a class of drugs that increase alertness, attention, energy, and/or mood by directly acting on the brain. They can be prescribed to treat medical conditions such as narcolepsy, attention deficit hyperactivity disorder (ADHD), and depression that has not responded to other treatments.

Examples of CNS stimulants include amphetamine (Adderall), methylphenidate (Ritalin, Concerta), and modafinil (Provigil). These medications work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain.

In addition to their therapeutic uses, CNS stimulants are also sometimes misused for non-medical reasons, such as to enhance cognitive performance or to get high. However, it's important to note that misusing these drugs can lead to serious health consequences, including addiction, cardiovascular problems, and mental health issues.

Wakefulness is a state of consciousness in which an individual is alert and aware of their surroundings. It is characterized by the ability to perceive, process, and respond to stimuli in a purposeful manner. In a medical context, wakefulness is often assessed using measures such as the electroencephalogram (EEG) to evaluate brain activity patterns associated with consciousness.

Wakefulness is regulated by several interconnected neural networks that promote arousal and attention. These networks include the ascending reticular activating system (ARAS), which consists of a group of neurons located in the brainstem that project to the thalamus and cerebral cortex, as well as other regions involved in regulating arousal and attention, such as the basal forebrain and hypothalamus.

Disorders of wakefulness can result from various underlying conditions, including neurological disorders, sleep disorders, medication side effects, or other medical conditions that affect brain function. Examples of such disorders include narcolepsy, insomnia, hypersomnia, and various forms of encephalopathy or brain injury.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Polysomnography (PSG) is a comprehensive sleep study that monitors various body functions during sleep, including brain activity, eye movement, muscle tone, heart rate, respirations, and oxygen levels. It is typically conducted in a sleep laboratory under the supervision of a trained technologist. The data collected during PSG is used to diagnose and manage various sleep disorders such as sleep-related breathing disorders (e.g., sleep apnea), movement disorders (e.g., periodic limb movement disorder), parasomnias, and narcolepsy.

The study usually involves the attachment of electrodes to different parts of the body, such as the scalp, face, chest, and legs, to record electrical signals from the brain, eye movements, muscle activity, and heartbeats. Additionally, sensors may be placed on or near the nose and mouth to measure airflow, and a belt may be worn around the chest and abdomen to monitor breathing efforts. Oxygen levels are also monitored through a sensor attached to the finger or ear.

Polysomnography is often recommended when a sleep disorder is suspected based on symptoms or medical history, and other diagnostic tests have been inconclusive. The results of the study can help guide treatment decisions and improve overall sleep health.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

Sleep deprivation is a condition that occurs when an individual fails to get sufficient quality sleep or the recommended amount of sleep, typically 7-9 hours for adults. This can lead to various physical and mental health issues. It can be acute, lasting for one night or a few days, or chronic, persisting over a longer period.

The consequences of sleep deprivation include:

1. Fatigue and lack of energy
2. Difficulty concentrating or remembering things
3. Mood changes, such as irritability or depression
4. Weakened immune system
5. Increased appetite and potential weight gain
6. Higher risk of accidents due to decreased reaction time
7. Health problems like high blood pressure, diabetes, and heart disease over time

Sleep deprivation can be caused by various factors, including stress, shift work, sleep disorders like insomnia or sleep apnea, poor sleep hygiene, and certain medications. It's essential to address the underlying causes of sleep deprivation to ensure proper rest and overall well-being.

Cyclohexanecarboxylic acids are a type of organic compound that consists of a cyclohexane ring, which is a six-carbon saturated hydrocarbon, substituted with a carboxylic acid group (-COOH). This group contains a carbon atom double bonded to an oxygen atom and single bonded to a hydroxyl group (-OH).

The cyclohexane ring can be in various forms, including the chair, boat, or twist-boat conformations, depending on the orientation of its constituent atoms. The carboxylic acid group can ionize to form a carboxylate anion, which is negatively charged and has a deprotonated hydroxyl group.

Cyclohexanecarboxylic acids have various applications in industry and research, including as intermediates in the synthesis of other chemicals, solvents, and pharmaceuticals. They can also be found naturally in some plants and microorganisms.

Sleep apnea syndromes refer to a group of disorders characterized by abnormal breathing patterns during sleep. These patterns can result in repeated pauses in breathing (apneas) or shallow breaths (hypopneas), causing interruptions in sleep and decreased oxygen supply to the body. There are three main types of sleep apnea syndromes:

1. Obstructive Sleep Apnea (OSA): This is the most common form, caused by the collapse or obstruction of the upper airway during sleep, often due to relaxation of the muscles in the throat and tongue.

2. Central Sleep Apnea (CSA): This type is less common and results from the brain's failure to send proper signals to the breathing muscles. It can be associated with conditions such as heart failure, stroke, or certain medications.

3. Complex/Mixed Sleep Apnea: In some cases, a person may experience both obstructive and central sleep apnea symptoms, known as complex or mixed sleep apnea.

Symptoms of sleep apnea syndromes can include loud snoring, excessive daytime sleepiness, fatigue, morning headaches, difficulty concentrating, and mood changes. Diagnosis typically involves a sleep study (polysomnography) to monitor breathing patterns, heart rate, brain activity, and other physiological factors during sleep. Treatment options may include lifestyle modifications, oral appliances, positive airway pressure therapy, or even surgery in severe cases.

Epilepsy is a chronic neurological disorder characterized by recurrent, unprovoked seizures. These seizures are caused by abnormal electrical activity in the brain, which can result in a wide range of symptoms, including convulsions, loss of consciousness, and altered sensations or behaviors. Epilepsy can have many different causes, including genetic factors, brain injury, infection, or stroke. In some cases, the cause may be unknown.

There are many different types of seizures that can occur in people with epilepsy, and the specific type of seizure will depend on the location and extent of the abnormal electrical activity in the brain. Some people may experience only one type of seizure, while others may have several different types. Seizures can vary in frequency, from a few per year to dozens or even hundreds per day.

Epilepsy is typically diagnosed based on the patient's history of recurrent seizures and the results of an electroencephalogram (EEG), which measures the electrical activity in the brain. Imaging tests such as MRI or CT scans may also be used to help identify any structural abnormalities in the brain that may be contributing to the seizures.

While there is no cure for epilepsy, it can often be effectively managed with medication. In some cases, surgery may be recommended to remove the area of the brain responsible for the seizures. With proper treatment and management, many people with epilepsy are able to lead normal, productive lives.

Electroencephalography (EEG) is a medical procedure that records electrical activity in the brain. It uses small, metal discs called electrodes, which are attached to the scalp with paste or a specialized cap. These electrodes detect tiny electrical charges that result from the activity of brain cells, and the EEG machine then amplifies and records these signals.

EEG is used to diagnose various conditions related to the brain, such as seizures, sleep disorders, head injuries, infections, and degenerative diseases like Alzheimer's or Parkinson's. It can also be used during surgery to monitor brain activity and ensure that surgical procedures do not interfere with vital functions.

EEG is a safe and non-invasive procedure that typically takes about 30 minutes to an hour to complete, although longer recordings may be necessary in some cases. Patients are usually asked to relax and remain still during the test, as movement can affect the quality of the recording.

Major Depressive Disorder (MDD), also simply referred to as depression, is a serious mental health condition characterized by the presence of one or more major depressive episodes. A major depressive episode is a period of at least two weeks during which an individual experiences a severely depressed mood and/or loss of interest or pleasure in nearly all activities, accompanied by at least four additional symptoms such as significant changes in appetite or weight, sleep disturbances, psychomotor agitation or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt, difficulty thinking, concentrating, or making decisions, and recurrent thoughts of death or suicide.

MDD can significantly impair an individual's ability to function in daily life, and it is associated with increased risks of suicide, substance abuse, and other mental health disorders. The exact cause of MDD is not fully understood, but it is believed to result from a complex interplay of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of psychotherapy (such as cognitive-behavioral therapy) and medication (such as selective serotonin reuptake inhibitors or tricyclic antidepressants).

Fatigue is a state of feeling very tired, weary, or exhausted, which can be physical, mental, or both. It is a common symptom that can be caused by various factors, including lack of sleep, poor nutrition, stress, medical conditions (such as anemia, diabetes, heart disease, or cancer), medications, and substance abuse. Fatigue can also be a symptom of depression or other mental health disorders. In medical terms, fatigue is often described as a subjective feeling of tiredness that is not proportional to recent activity levels and interferes with usual functioning. It is important to consult a healthcare professional if experiencing persistent or severe fatigue to determine the underlying cause and develop an appropriate treatment plan.

I couldn't find a medical definition specifically for "delayed-action preparations." However, in the context of pharmacology, it may refer to medications or treatments that have a delayed onset of action. These are designed to release the active drug slowly over an extended period, which can help to maintain a consistent level of the medication in the body and reduce the frequency of dosing.

Examples of delayed-action preparations include:

1. Extended-release (ER) or controlled-release (CR) formulations: These are designed to release the drug slowly over several hours, reducing the need for frequent dosing. Examples include extended-release tablets and capsules.
2. Transdermal patches: These deliver medication through the skin and can provide a steady rate of drug delivery over several days. Examples include nicotine patches for smoking cessation or fentanyl patches for pain management.
3. Injectable depots: These are long-acting injectable formulations that slowly release the drug into the body over weeks to months. An example is the use of long-acting antipsychotic injections for the treatment of schizophrenia.
4. Implantable devices: These are small, biocompatible devices placed under the skin or within a body cavity that release a steady dose of medication over an extended period. Examples include hormonal implants for birth control or drug-eluting stents used in cardiovascular procedures.

Delayed-action preparations can improve patient compliance and quality of life by reducing dosing frequency, minimizing side effects, and maintaining consistent therapeutic levels.

Attention Deficit Hyperactivity Disorder (ADHD) with hyperactivity is a neurodevelopmental disorder that affects both children and adults. The condition is characterized by symptoms including:

1. Difficulty paying attention or staying focused on a single task
2. Impulsivity, or acting without thinking
3. Hyperactivity, or excessive fidgeting, restlessness, or talking

In order to be diagnosed with ADHD with hyperactivity, an individual must exhibit these symptoms to a degree that is developmentally inappropriate and interferes with their daily functioning. Additionally, the symptoms must have been present for at least six months and be present in multiple settings (e.g., at home, school, work).

It's important to note that ADHD can manifest differently in different people, and some individuals may experience predominantly inattentive or impulsive symptoms rather than hyperactive ones. However, when the hyperactive component is prominent, it is referred to as ADHD with hyperactivity.

Effective treatments for ADHD with hyperactivity include a combination of medication (such as stimulants) and behavioral therapy. With appropriate treatment, individuals with ADHD can learn to manage their symptoms and lead successful, fulfilling lives.

Antipsychotic agents are a class of medications used to manage and treat psychosis, which includes symptoms such as delusions, hallucinations, paranoia, disordered thought processes, and agitated behavior. These drugs work by blocking the action of dopamine, a neurotransmitter in the brain that is believed to play a role in the development of psychotic symptoms. Antipsychotics can be broadly divided into two categories: first-generation antipsychotics (also known as typical antipsychotics) and second-generation antipsychotics (also known as atypical antipsychotics).

First-generation antipsychotics, such as chlorpromazine, haloperidol, and fluphenazine, were developed in the 1950s and have been widely used for several decades. They are generally effective in reducing positive symptoms of psychosis (such as hallucinations and delusions) but can cause significant side effects, including extrapyramidal symptoms (EPS), such as rigidity, tremors, and involuntary movements, as well as weight gain, sedation, and orthostatic hypotension.

Second-generation antipsychotics, such as clozapine, risperidone, olanzapine, quetiapine, and aripiprazole, were developed more recently and are considered to have a more favorable side effect profile than first-generation antipsychotics. They are generally effective in reducing both positive and negative symptoms of psychosis (such as apathy, anhedonia, and social withdrawal) and cause fewer EPS. However, they can still cause significant weight gain, metabolic disturbances, and sedation.

Antipsychotic agents are used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder with psychotic features, delusional disorder, and other conditions that involve psychosis or agitation. They can be administered orally, intramuscularly, or via long-acting injectable formulations. The choice of antipsychotic agent depends on the individual patient's needs, preferences, and response to treatment, as well as the potential for side effects. Regular monitoring of patients taking antipsychotics is essential to ensure their safety and effectiveness.

A depressive disorder is a mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest or pleasure in activities. It can also include changes in sleep, appetite, energy levels, concentration, and self-esteem, as well as thoughts of death or suicide. Depressive disorders can vary in severity and duration, with some people experiencing mild and occasional symptoms, while others may have severe and chronic symptoms that interfere with their ability to function in daily life.

There are several types of depressive disorders, including major depressive disorder (MDD), persistent depressive disorder (PDD), and postpartum depression. MDD is characterized by symptoms that interfere significantly with a person's ability to function and last for at least two weeks, while PDD involves chronic low-grade depression that lasts for two years or more. Postpartum depression occurs in women after childbirth and can range from mild to severe.

Depressive disorders are thought to be caused by a combination of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of medication, psychotherapy (talk therapy), and lifestyle changes.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

Obstructive Sleep Apnea (OSA) is a sleep-related breathing disorder that occurs when the upper airway becomes partially or completely blocked during sleep, leading to pauses in breathing or shallow breaths. These episodes, known as apneas or hypopneas, can last for 10 seconds or longer and may occur multiple times throughout the night, disrupting normal sleep patterns and causing oxygen levels in the blood to drop.

The obstruction in OSA is typically caused by the relaxation of the muscles in the back of the throat during sleep, which allows the soft tissues to collapse and block the airway. This can result in snoring, choking, gasping for air, or awakening from sleep with a start.

Contributing factors to OSA may include obesity, large neck circumference, enlarged tonsils or adenoids, alcohol consumption, smoking, and use of sedatives or muscle relaxants. Untreated OSA can lead to serious health consequences such as high blood pressure, heart disease, stroke, diabetes, and cognitive impairment. Treatment options for OSA include lifestyle changes, oral appliances, positive airway pressure therapy, and surgery.

Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by the presence of obsessions and compulsions. Obsessions are recurrent and persistent thoughts, urges, or images that are intrusive, unwanted, and often distressing. Compulsions are repetitive behaviors or mental acts that an individual feels driven to perform in response to an obsession or according to rigid rules, and which are aimed at preventing or reducing anxiety or distress, or preventing some dreaded event or situation. These obsessions and/or compulsions cause significant distress, take up a lot of time (an hour or more a day), and interfere with the individual's daily life, including social activities, relationships, and work or school performance. OCD is considered a type of anxiety disorder and can also co-occur with other mental health conditions.

Analgesics are a class of drugs that are used to relieve pain. They work by blocking the transmission of pain signals in the nervous system, allowing individuals to manage their pain levels more effectively. There are many different types of analgesics available, including both prescription and over-the-counter options. Some common examples include acetaminophen (Tylenol), ibuprofen (Advil or Motrin), and opioids such as morphine or oxycodone.

The choice of analgesic will depend on several factors, including the type and severity of pain being experienced, any underlying medical conditions, potential drug interactions, and individual patient preferences. It is important to use these medications as directed by a healthcare provider, as misuse or overuse can lead to serious side effects and potential addiction.

In addition to their pain-relieving properties, some analgesics may also have additional benefits such as reducing inflammation (like in the case of nonsteroidal anti-inflammatory drugs or NSAIDs) or causing sedation (as with certain opioids). However, it is essential to weigh these potential benefits against the risks and side effects associated with each medication.

When used appropriately, analgesics can significantly improve a person's quality of life by helping them manage their pain effectively and allowing them to engage in daily activities more comfortably.

Post-traumatic stress disorder (PTSD) is a psychiatric condition that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, serious accident, war combat, rape, or violent personal assault. According to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), PTSD is characterized by the following symptoms, which must last for more than one month:

1. Intrusion symptoms: These include distressing memories, nightmares, flashbacks, or intense psychological distress or reactivity to internal or external cues that symbolize or resemble an aspect of the traumatic event.
2. Avoidance symptoms: Persistent avoidance of stimuli associated with the traumatic event, including thoughts, feelings, conversations, activities, places, or people.
3. Negative alterations in cognitions and mood: This includes negative beliefs about oneself, others, or the world; distorted blame of self or others for causing the trauma; persistent negative emotional state; decreased interest in significant activities; and feelings of detachment or estrangement from others.
4. Alterations in arousal and reactivity: This includes irritable behavior and angry outbursts, reckless or self-destructive behavior, hypervigilance, exaggerated startle response, problems with concentration, and sleep disturbance.
5. Duration of symptoms: The symptoms must last for more than one month.
6. Functional significance: The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.

It is essential to note that PTSD can occur at any age and can be accompanied by various physical and mental health problems, such as depression, substance abuse, memory problems, and other difficulties in cognition. Appropriate treatment, which may include psychotherapy, medication, or a combination of both, can significantly improve the symptoms and overall quality of life for individuals with PTSD.

Autistic Disorder, also known as Autism or Classic Autism, is a neurodevelopmental disorder that affects communication and behavior. It is characterized by:

1. Persistent deficits in social communication and social interaction across multiple contexts, including:
* Deficits in social-emotional reciprocity;
* Deficits in nonverbal communicative behaviors used for social interaction;
* Deficits in developing, maintaining, and understanding relationships.
2. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at least two of the following:
* Stereotyped or repetitive motor movements, use of objects, or speech;
* Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal or nonverbal behavior;
* Highly restricted, fixated interests that are abnormal in intensity or focus;
* Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment.
3. Symptoms must be present in the early developmental period (but may not become fully manifest until social demands exceed limited capacities) and limit or impair everyday functioning.
4. Symptoms do not occur exclusively during the course of a schizophrenia spectrum disorder or other psychotic disorders.

Autistic Disorder is part of the autism spectrum disorders (ASDs), which also include Asperger's Syndrome and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). The current diagnostic term for this category of conditions, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), is Autism Spectrum Disorder.

"Drug evaluation" is a medical term that refers to the systematic process of assessing the pharmacological, therapeutic, and safety profile of a drug or medication. This process typically involves several stages, including preclinical testing in the laboratory, clinical trials in human subjects, and post-marketing surveillance.

The goal of drug evaluation is to determine the efficacy, safety, and optimal dosage range of a drug, as well as any potential interactions with other medications or medical conditions. The evaluation process also includes an assessment of the drug's pharmacokinetics, or how it is absorbed, distributed, metabolized, and eliminated by the body.

The findings from drug evaluations are used to inform regulatory decisions about whether a drug should be approved for use in clinical practice, as well as to provide guidance to healthcare providers about how to use the drug safely and effectively.

I apologize for any confusion, but "Argentina" is a country in South America and not a medical term or concept. The term "argyria" may be what you're looking for, which is a rare condition resulting from the accumulation of silver compounds in the body, causing the skin to turn blue-gray. However, Argentina and argyria are two distinct terms with different meanings.

A questionnaire in the medical context is a standardized, systematic, and structured tool used to gather information from individuals regarding their symptoms, medical history, lifestyle, or other health-related factors. It typically consists of a series of written questions that can be either self-administered or administered by an interviewer. Questionnaires are widely used in various areas of healthcare, including clinical research, epidemiological studies, patient care, and health services evaluation to collect data that can inform diagnosis, treatment planning, and population health management. They provide a consistent and organized method for obtaining information from large groups or individual patients, helping to ensure accurate and comprehensive data collection while minimizing bias and variability in the information gathered.

A phobic disorder is a type of anxiety disorder characterized by an excessive and irrational fear or avoidance of specific objects, situations, or activities. This fear can cause significant distress and interfere with a person's daily life. Phobic disorders are typically classified into three main categories: specific phobias (such as fear of heights, spiders, or needles), social phobia (or social anxiety disorder), and agoraphobia (fear of open spaces or situations where escape might be difficult).

People with phobic disorders often recognize that their fear is excessive or unreasonable, but they are unable to control it. When exposed to the feared object or situation, they may experience symptoms such as rapid heartbeat, sweating, trembling, and difficulty breathing. These symptoms can be so distressing that individuals with phobic disorders go to great lengths to avoid the feared situation, which can have a significant impact on their quality of life.

Treatment for phobic disorders typically involves cognitive-behavioral therapy (CBT), which helps individuals identify and challenge their irrational thoughts and fears, as well as exposure therapy, which gradually exposes them to the feared object or situation in a safe and controlled environment. In some cases, medication may also be recommended to help manage symptoms of anxiety.

Gamma-Aminobutyric Acid (GABA) is a major inhibitory neurotransmitter in the mammalian central nervous system. It plays a crucial role in regulating neuronal excitability and preventing excessive neuronal firing, which helps to maintain neural homeostasis and reduce the risk of seizures. GABA functions by binding to specific receptors (GABA-A, GABA-B, and GABA-C) on the postsynaptic membrane, leading to hyperpolarization of the neuronal membrane and reduced neurotransmitter release from presynaptic terminals.

In addition to its role in the central nervous system, GABA has also been identified as a neurotransmitter in the peripheral nervous system, where it is involved in regulating various physiological processes such as muscle relaxation, hormone secretion, and immune function.

GABA can be synthesized in neurons from glutamate, an excitatory neurotransmitter, through the action of the enzyme glutamic acid decarboxylase (GAD). Once synthesized, GABA is stored in synaptic vesicles and released into the synapse upon neuronal activation. After release, GABA can be taken up by surrounding glial cells or degraded by the enzyme GABA transaminase (GABA-T) into succinic semialdehyde, which is further metabolized to form succinate and enter the Krebs cycle for energy production.

Dysregulation of GABAergic neurotransmission has been implicated in various neurological and psychiatric disorders, including epilepsy, anxiety, depression, and sleep disturbances. Therefore, modulating GABAergic signaling through pharmacological interventions or other therapeutic approaches may offer potential benefits for the treatment of these conditions.

Pervasive developmental disorders (PDD) are a group of conditions that affect the development and functioning of the brain, leading to delays in many areas of development. The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) has replaced the term "pervasive developmental disorders" with "autism spectrum disorder" and "other neurodevelopmental disorders."

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction across multiple contexts, as well as restricted, repetitive patterns of behavior, interests, or activities. The symptoms of ASD can range from mild to severe, and the condition affects approximately 1 in 54 children in the United States.

Other neurodevelopmental disorders that were previously classified as PDDs include:

1. Intellectual disability (ID): a condition characterized by significant limitations in intellectual functioning and adaptive behavior, which covers many everyday social and practical skills. This disorder used to be referred to as "mental retardation."
2. Communication disorders: these are disorders that affect an individual's ability to communicate, including language disorders, speech sound disorders, and stuttering.
3. Attention-deficit/hyperactivity disorder (ADHD): a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity.
4. Specific learning disorder: a neurodevelopmental disorder that affects an individual's ability to learn and use specific academic skills, such as reading, writing, or mathematics.
5. Motor disorders: these are disorders that affect an individual's movement and coordination, including developmental coordination disorder, stereotypic movement disorder, and tic disorders.

The medical definition of 'Child Development Disorders, Pervasive' has been replaced with more specific diagnoses in the DSM-5 to better reflect the diverse nature of these conditions and improve diagnostic accuracy and treatment planning.

Psychotic disorders are a group of severe mental health conditions characterized by distorted perceptions, thoughts, and emotions that lead to an inability to recognize reality. The two most common symptoms of psychotic disorders are hallucinations and delusions. Hallucinations are when a person sees, hears, or feels things that aren't there, while delusions are fixed, false beliefs that are not based on reality.

Other symptoms may include disorganized speech, disorganized behavior, catatonic behavior, and negative symptoms such as apathy and lack of emotional expression. Schizophrenia is the most well-known psychotic disorder, but other types include schizoaffective disorder, delusional disorder, brief psychotic disorder, shared psychotic disorder, and substance-induced psychotic disorder.

Psychotic disorders can be caused by a variety of factors, including genetics, brain chemistry imbalances, trauma, and substance abuse. Treatment typically involves a combination of medication, therapy, and support services to help manage symptoms and improve quality of life.

Substance-related disorders, as defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), refer to a group of conditions caused by the use of substances such as alcohol, drugs, or medicines. These disorders are characterized by a problematic pattern of using a substance that leads to clinically significant impairment or distress. They can be divided into two main categories: substance use disorders and substance-induced disorders. Substance use disorders involve a pattern of compulsive use despite negative consequences, while substance-induced disorders include conditions such as intoxication, withdrawal, and substance/medication-induced mental disorders. The specific diagnosis depends on the type of substance involved, the patterns of use, and the presence or absence of physiological dependence.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

A "Drug Administration Schedule" refers to the plan for when and how a medication should be given to a patient. It includes details such as the dose, frequency (how often it should be taken), route (how it should be administered, such as orally, intravenously, etc.), and duration (how long it should be taken) of the medication. This schedule is often created and prescribed by healthcare professionals, such as doctors or pharmacists, to ensure that the medication is taken safely and effectively. It may also include instructions for missed doses or changes in the dosage.

Oral administration is a route of giving medications or other substances by mouth. This can be in the form of tablets, capsules, liquids, pastes, or other forms that can be swallowed. Once ingested, the substance is absorbed through the gastrointestinal tract and enters the bloodstream to reach its intended target site in the body. Oral administration is a common and convenient route of medication delivery, but it may not be appropriate for all substances or in certain situations, such as when rapid onset of action is required or when the patient has difficulty swallowing.

Conduct Disorder is a mental health disorder that typically begins in childhood or adolescence and is characterized by a repetitive pattern of behavior that violates the rights of others or major age-appropriate societal norms and rules. The behaviors fall into four main categories: aggression to people and animals, destruction of property, deceitfulness or theft, and serious violation of rules.

The specific symptoms of Conduct Disorder can vary widely among individuals, but they generally include:

1. Aggression to people and animals: This may include physical fights, bullying, threatening others, cruelty to animals, and use of weapons.
2. Destruction of property: This may include deliberate destruction of others' property, arson, and vandalism.
3. Deceitfulness or theft: This may include lying, shoplifting, stealing, and breaking into homes, buildings, or cars.
4. Serious violation of rules: This may include running away from home, truancy, staying out late without permission, and frequent violations of school rules.

Conduct Disorder can have serious consequences for individuals who suffer from it, including academic failure, substance abuse, depression, anxiety, and difficulties in interpersonal relationships. It is important to note that Conduct Disorder should be diagnosed by a qualified mental health professional based on a comprehensive evaluation.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Tic disorders are a group of conditions characterized by the presence of repetitive, involuntary movements or sounds, known as tics. These movements or sounds can vary in complexity and severity, and they may be worsened by stress or strong emotions.

There are several different types of tic disorders, including:

1. Tourette's disorder: This is a neurological condition characterized by the presence of both motor (movement-related) and vocal tics that have been present for at least one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
2. Persistent (chronic) motor or vocal tic disorder: This type of tic disorder is characterized by the presence of either motor or vocal tics (but not both), which have been present for at least one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
3. Provisional tic disorder: This type of tic disorder is characterized by the presence of motor or vocal tics (or both) that have been present for less than one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
4. Tic disorder not otherwise specified: This category is used to describe tic disorders that do not meet the criteria for any of the other types of tic disorders.

Tic disorders are thought to be caused by a combination of genetic and environmental factors, and they often co-occur with other conditions such as attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). Treatment for tic disorders may include behavioral therapy, medication, or a combination of both.

Psychiatric Status Rating Scales are standardized assessment tools used by mental health professionals to evaluate and rate the severity of a person's psychiatric symptoms and functioning. These scales provide a systematic and structured approach to measuring various aspects of an individual's mental health, such as mood, anxiety, psychosis, behavior, and cognitive abilities.

The purpose of using Psychiatric Status Rating Scales is to:

1. Assess the severity and improvement of psychiatric symptoms over time.
2. Aid in diagnostic decision-making and treatment planning.
3. Monitor treatment response and adjust interventions accordingly.
4. Facilitate communication among mental health professionals about a patient's status.
5. Provide an objective basis for research and epidemiological studies.

Examples of Psychiatric Status Rating Scales include:

1. Clinical Global Impression (CGI): A brief, subjective rating scale that measures overall illness severity, treatment response, and improvement.
2. Positive and Negative Syndrome Scale (PANSS): A comprehensive scale used to assess the symptoms of psychosis, including positive, negative, and general psychopathology domains.
3. Hamilton Rating Scale for Depression (HRSD) or Montgomery-Åsberg Depression Rating Scale (MADRS): Scales used to evaluate the severity of depressive symptoms.
4. Young Mania Rating Scale (YMRS): A scale used to assess the severity of manic or hypomanic symptoms.
5. Brief Psychiatric Rating Scale (BPRS) or Symptom Checklist-90 Revised (SCL-90-R): Scales that measure a broad range of psychiatric symptoms and psychopathology.
6. Global Assessment of Functioning (GAF): A scale used to rate an individual's overall psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness.

It is important to note that Psychiatric Status Rating Scales should be administered by trained mental health professionals to ensure accurate and reliable results.

Borderline Personality Disorder (BPD) is a mental health disorder characterized by a pervasive pattern of instability in interpersonal relationships, self-image, affect, and mood, as well as marked impulsivity that begins by early adulthood and is present in various contexts.

Individuals with BPD often experience intense and fluctuating emotions, ranging from profound sadness, anxiety, and anger to feelings of happiness or calm. They may have difficulty managing these emotions, leading to impulsive behavior, self-harm, or suicidal ideation.

People with BPD also tend to have an unstable sense of self, which can lead to rapid changes in their goals, values, and career choices. They often struggle with feelings of emptiness and boredom, and may engage in risky behaviors such as substance abuse, reckless driving, or binge eating to alleviate these feelings.

Interpersonal relationships are often strained due to the individual's fear of abandonment, intense emotional reactions, and difficulty regulating their emotions. They may experience idealization and devaluation of others, leading to rapid shifts in how they view and treat people close to them.

Diagnosis of BPD is typically made by a mental health professional using criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which is published by the American Psychiatric Association. Treatment for BPD may include psychotherapy, medication, and support groups to help individuals manage their symptoms and improve their quality of life.

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

Somatoform disorders are a group of psychological disorders characterized by the presence of physical symptoms that cannot be fully explained by a medical condition or substance abuse. These symptoms cause significant distress and impairment in social, occupational, or other important areas of functioning. The individual's belief about the symptoms is not consistent with the medical evaluation and often leads to excessive or repeated medical evaluations.

Examples of somatoform disorders include:

1. Somatization disorder: characterized by multiple physical symptoms that cannot be explained medically, affecting several parts of the body.
2. Conversion disorder: characterized by the presence of one or more neurological symptoms (such as blindness, paralysis, or difficulty swallowing) that cannot be explained medically and appear to have a psychological origin.
3. Pain disorder: characterized by chronic pain that is not fully explained by a medical condition.
4. Hypochondriasis: characterized by an excessive preoccupation with having a serious illness, despite reassurance from medical professionals.
5. Body dysmorphic disorder: characterized by the obsessive idea that some aspect of one's own body part or appearance is severely flawed and warrants exceptional measures to hide or fix it.

It's important to note that these disorders are not caused by intentional deceit or malingering, but rather reflect a genuine belief in the presence of physical symptoms and distress related to them.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

Cognitive disorders are a category of mental health disorders that primarily affect cognitive abilities including learning, memory, perception, and problem-solving. These disorders can be caused by various factors such as brain injury, degenerative diseases, infection, substance abuse, or developmental disabilities. Examples of cognitive disorders include dementia, amnesia, delirium, and intellectual disability. It's important to note that the specific definition and diagnostic criteria for cognitive disorders may vary depending on the medical source or classification system being used.

Lymphoproliferative disorders (LPDs) are a group of diseases characterized by the excessive proliferation of lymphoid cells, which are crucial components of the immune system. These disorders can arise from both B-cells and T-cells, leading to various clinical manifestations ranging from benign to malignant conditions.

LPDs can be broadly classified into reactive and neoplastic categories:

1. Reactive Lymphoproliferative Disorders: These are typically triggered by infections, autoimmune diseases, or immunodeficiency states. They involve an exaggerated response of the immune system leading to the excessive proliferation of lymphoid cells. Examples include:
* Infectious mononucleosis (IM) caused by Epstein-Barr virus (EBV)
* Lymph node enlargement due to various infections or autoimmune disorders
* Post-transplant lymphoproliferative disorder (PTLD), which occurs in the context of immunosuppression following organ transplantation
2. Neoplastic Lymphoproliferative Disorders: These are malignant conditions characterized by uncontrolled growth and accumulation of abnormal lymphoid cells, leading to the formation of tumors. They can be further classified into Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Examples include:
* Hodgkin lymphoma (HL): Classical HL and nodular lymphocyte-predominant HL
* Non-Hodgkin lymphoma (NHL): Various subtypes, such as diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Burkitt lymphoma

It is important to note that the distinction between reactive and neoplastic LPDs can sometimes be challenging, requiring careful clinical, histopathological, immunophenotypic, and molecular evaluations. Proper diagnosis and classification of LPDs are crucial for determining appropriate treatment strategies and predicting patient outcomes.

Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.

Neoplasms are abnormal growths of cells or tissues in the body that serve no physiological function. They can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow growing and do not spread to other parts of the body, while malignant neoplasms are aggressive, invasive, and can metastasize to distant sites.

Neoplasms occur when there is a dysregulation in the normal process of cell division and differentiation, leading to uncontrolled growth and accumulation of cells. This can result from genetic mutations or other factors such as viral infections, environmental exposures, or hormonal imbalances.

Neoplasms can develop in any organ or tissue of the body and can cause various symptoms depending on their size, location, and type. Treatment options for neoplasms include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy, among others.

According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), alcohol-related disorders are a category of mental disorders defined by a problematic pattern of alcohol use that leads to clinically significant impairment or distress. The disorders include:

1. Alcohol Use Disorder (AUD): A chronic relapsing brain disorder characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. AUD can be mild, moderate, or severe, and recovery is possible regardless of severity. The symptoms include problems controlling intake of alcohol, continued use despite problems resulting from drinking, development of a tolerance, drinking that leads to risky situations, or withdrawal symptoms when not drinking.
2. Alcohol Intoxication: A state of acute impairment in mental and motor function caused by the recent consumption of alcohol. The symptoms include slurred speech, unsteady gait, nystagmus, impaired attention or memory, stupor, or coma. In severe cases, it can lead to respiratory depression, hypothermia, or even death.
3. Alcohol Withdrawal: A syndrome that occurs when alcohol use is heavily reduced or stopped after prolonged and heavy use. The symptoms include autonomic hyperactivity, increased hand tremor, insomnia, nausea or vomiting, transient visual, tactile, or auditory hallucinations or illusions, psychomotor agitation, anxiety, and grand mal seizures.
4. Other Alcohol-Induced Disorders: These include alcohol-induced sleep disorder, alcohol-induced sexual dysfunction, and alcohol-induced major neurocognitive disorder.

It is important to note that alcohol use disorders are complex conditions that can be influenced by a variety of factors, including genetics, environment, and personal behavior. If you or someone you know is struggling with alcohol use, it is recommended to seek professional help.

Movement disorders are a group of neurological conditions that affect the control and coordination of voluntary movements. These disorders can result from damage to or dysfunction of the cerebellum, basal ganglia, or other parts of the brain that regulate movement. Symptoms may include tremors, rigidity, bradykinesia (slowness of movement), akathisia (restlessness and inability to remain still), dystonia (sustained muscle contractions leading to abnormal postures), chorea (rapid, unpredictable movements), tics, and gait disturbances. Examples of movement disorders include Parkinson's disease, Huntington's disease, Tourette syndrome, and dystonic disorders.

"Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: A case-control study". Sleep. 28 (6): 667- ... It should be used with extreme caution in people with bipolar disorder due to the potential induction of mania or hypomania. ... Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and addictive disorders". In Sydor A, Brown RY (eds.). ... de Sousa A, Kalra G (January 2012). "Drug therapy of attention deficit hyperactivity disorder: current trends". Mens Sana ...
"Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: A case-control study". Sleep. 28 (6): 667- ... Excessive doses of methylphenidate, above the therapeutic range, can interfere with working memory and cognitive control. Like ... It should be used with extreme caution in people with bipolar disorder due to the potential induction of mania or hypomania. ... Attention deficit hyperactivity disorder (ADHD). 1 June 2018. Retrieved 24 October 2022. Robison LS, Ananth M, Hadjiargyrou M, ...
... such as excessive daytime sleepiness, shift work sleep disorder, and others; and there are medical codes for somnolence as ... Somnolence is often viewed as a symptom rather than a disorder by itself. However, the concept of somnolence recurring at ... The word "somnolence" is derived from the Latin "somnus" meaning "sleep". Circadian rhythm ("biological clock") disorders are a ... The body clock disorders are classified as extrinsic (externally caused) or intrinsic. The former type is, for example, shift ...
A polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence". Electroencephalography ... or as a symptom of another underlying disorder like narcolepsy, circadian rhythm sleep disorder, sleep apnea or idiopathic ... or other circadian rhythm sleep disorders); another underlying sleep disorder, such as narcolepsy, sleep apnea, idiopathic ... Excessive daytime sleepiness (EDS) is characterized by persistent sleepiness and often a general lack of energy, even during ...
It is used to diagnose disorders of excessive somnolence, such as hypersomnia, narcolepsy or obstructive sleep apnea. During ... Hypersomnia is a neurological disorder of excessive time spent sleeping or excessive sleepiness. It can have many possible ... Mood disorders, like depression, anxiety disorder and bipolar disorder, can also be associated with hypersomnia. The complaint ... Sleep movement disorders, such as restless legs syndrome (RLS) and periodic limb movement disorder (PLMD or PLMS) can also ...
The most common side effects of treatment with ganaxolone include somnolence (sleepiness), fever, excessive saliva or drooling ... These include the study of participants with cyclin-dependent kinase-like 5 deficiency disorder and a clinical study that ... deficiency disorder who were two years of age and older. The trial was conducted at 36 sites in 8 countries including Australia ... deficiency disorder. The exact mechanism of action for ganaxolone is unknown; however, results from animal studies suggest that ...
... (IH) is a neurological disorder which is characterized primarily by excessive sleep and excessive ... IH can profoundly affect work, education, and quality of life due to excessive daytime somnolence. Patients will often need to ... June 2011). "Effect of levothyroxine on prolonged nocturnal sleep time and excessive daytime somnolence in patients with ... The latest ICD 10 defines IH with long sleep time as a neurological disorder that is a rare sleep disorder characterized by ...
... balance disorder, gait disturbance, increased blood pressure, drooling, excessive salivation, fever, upper respiratory tract ... Side effects of fenfluramine in people treated for seizures include decreased appetite, somnolence, sedation, lethargy, ... balance disorder, gait disturbance (trouble with walking); increased blood pressure; drooling, salivary hypersecretion (saliva ...
Insomnias Disorders of Excessive somnolence (DOES) - Hypersomnias Disorders of the Sleep-Wake Schedule - Circadian Disorders ... rhythm disorder Non-24-hour sleep-wake rhythm disorder Shift work disorder Jet lag disorder Circadian sleep-wake disorder not ... Dyssomnias Intrinsic Sleep Disorders Extrinsic Sleep Disorders Circadian Rhythm Sleep Disorders Parasomnias Arousal Disorders ... The two last categories (i.e. sleep disorders associated with disorders classified elsewhere and psychiatric disorders ...
Some common symptoms are: Excessive daytime somnolence Insomnia, characterized mostly by sleep fragmentation Disturbances in ... Dysarthria is a form of speech disorder. Other motor symptoms and signs: Fatigue Hypomimia (a mask-like face). Difficulty ... Excessive sweating Parkinson's Disease causes constipation and gastric dysmotility that is severe enough to endanger comfort ... Rigidity is characterized by an increased muscle tone (an excessive and continuous contraction of the muscles) which produces ...
... excessive somnolence, and attention deficit hyperactivity disorder. "Mevidalen - Eli Lilly and Company". AdisInsight. Springer ... Besides for movement disorders and dementia, D1 receptor PAMs like mevidalen might have value in the treatment of certain ... Movement Disorders. 37 (3): 513-524. doi:10.1002/mds.28879. PMC 9300146. PMID 34859493. S2CID 244887088. Wilbraham D, Biglan KM ... A new mechanism for the treatment of neuropsychiatric disorders". Advances in Pharmacology. Advances in Pharmacology. Vol. 86. ...
Very common effects (>10% incidence) include: Headache (24%) Nausea (18%) Ejaculation disorder (9-14%) Somnolence (4-13%) ... Constipation Decreased or increased appetite Diarrhea Dilated pupils Dizziness Dry mouth Excessive sweating Fatigue Impotence ( ... general anxiety disorder (GAD), social anxiety disorder (SAD), obsessive-compulsive disorder (OCD), and panic disorder with or ... Escitalopram is mainly used to treat major depressive disorder and generalized anxiety disorder. It is taken by mouth, ...
... portal Psychology portal Medicine portal Cannabis use disorder Cognitive orthotics Depersonalization disorder Excessive daytime ... Post-chemotherapy cognitive impairment Pumphead syndrome Reactive hypoglycemia Sleep inertia Slow-wave sleep Somnolence Stupor ... Symptoms and signs of mental disorders, Symptoms and signs: Nervous system, Cognitive disorders, Psychopathological syndromes) ... The Diagnostic and Statistical Manual of Mental Disorders (DSM) has historically used the term in its definition of delirium. ...
... excessive sleep or somnolence (hypersomnia), a sensation of heaviness in limbs known as leaden paralysis, and significant ... Depressive and related disorders and bipolar and related disorders. Bipolar disorders fall in between depressive disorders and ... more than one mood disorder can be present in an individual, like bipolar disorder and depressive disorder. If a mood disorder ... A mood disorder, also known as an affective disorder, is any of a group of conditions of mental and behavioral disorder where a ...
... shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. For obstructive sleep ... "Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy ... 19 (1 Sleep Disorders): 132-147. doi:10.1212/01.CON.0000427209.21177.aa. PMC 3654533. PMID 23385698. European Medicines Agency ... Modafinil has been studied in the treatment of major depressive disorder. In a 2021 systematic review and meta-analysis of ...
... sleep disorders, intrinsic MeSH C10.886.425.800.200 - disorders of excessive somnolence MeSH C10.886.425.800.200.400 - ... headache disorders MeSH C10.228.140.546.399 - headache disorders, primary MeSH C10.228.140.546.399.750 - migraine disorders ... language development disorders MeSH C10.597.606.150.500.800 - speech disorders MeSH C10.597.606.150.500.800.100 - aphasia MeSH ... taste disorders MeSH C10.597.751.861.184 - ageusia MeSH C10.597.751.861.479 - dysgeusia MeSH C10.597.751.941 - vision disorders ...
Excessive daytime sleepiness can also be caused by other sleep disorders such as sleep apnea, major depressive disorder, anemia ... While cognitive impairment does occur, it may only be a reflection of the excessive daytime somnolence. In 2015, it was ... For a diagnosis of hypersomnolence disorder, the individual must present with excessive sleepiness despite at least 7 hours of ... Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, hypnagonic hallucinations, ...
Excessive amounts of valproic acid can result in somnolence, tremor, stupor, respiratory depression, coma, metabolic acidosis, ... Studies have shown this risk of PCOS is higher in women with epilepsy compared to those with bipolar disorder. Weight gain is ... It is used primarily to treat epilepsy and bipolar disorder. It is also used to prevent migraine headaches. Valproate has a ... The use of valproate for migraine or bipolar disorder during pregnancy is contraindicated in the European Union and the United ...
Particularly, somnolence is a recognized adverse effect of dopamine agonists, pramipexole and ropinirole. These drugs are known ... Swanson, L. M., ARNEDT, J., Rosekind, M. R., Belenky, G., Balkin, T. J., & Drake, C. (2011). "Sleep disorders and work ... Microsleeps that recur and negatively influence day-to-day living often are clustered into the category of excessive daytime ... Thus, most clinical studies related to microsleeps are in the context of reducing microsleeps in excessive daytime sleepiness ...
... or of excessive sleepiness. Dyssomnias are primary disorders of initiating or maintaining sleep or of excessive sleepiness and ... shift work sleep disorder. Parasomnia Sleep problems in women Somnolence American Academy of Sleep Medicine (2001). The ... Extrinsic sleep disorders - 13 disorders recognized, including: 16 alcohol-dependent sleep disorder, food allergy insomnia, ... Circadian rhythm sleep disorders, both intrinsic and extrinsic - 6 disorders recognized, including: 16 advanced sleep phase ...
"Excessive daytime somnolence in women with abnormal respiratory efforts during sleep." Sleep 16:S137-S138 Guilleminault, C.; ... Treating Sexual Disorders." Randolph S. Charltoon (ed): Publisher Jossey Bass, San Francisco, CA, Chapter 4, pp. 123-125 ... 106 (9): 1089-1093 Guilleminault, C; Stoohs, R; Kim, Y; Chervin, R; Black, J; Clerk, A. (1995) "Upper Airway sleep-disordered ... He was an attending physician and associate director of the Stanford Sleep Disorders Clinic at Stanford University Medical ...
Disorder of initiating and maintain sleep (DIMS) - Insomnias Disorder of Excessive sleep (DOES) - Hypersomnias Disorder of ... disorder Sleep-Wake Disorders Not Elsewhere Classified Insomnia Disorder Not Elsewhere Classified Major Somnolence Disorder ( ... phase disorder Irregular sleep-wake rhythm disorder Non-24-h sleep-wake rhythm disorder Shift work disorder Jet lag disorder ... Sleep Disorders Extrinsic Sleep Disorders Circadian Rhythm Sleep Disorders Arousal Disorders Sleep-Wake Transition Disorders ...
It may also be used short term in those with generalized anxiety disorder but is less preferred to benzodiazepines. It is of ... It is also more likely to cause somnolence and anticholinergic side effects such as red eye and xerostomia (dry mouth). All ... The antimuscarinic action of trifluoperazine can cause excessive dilation of the pupils (mydriasis), which increases the ... It appears to be effective for people with generalized anxiety disorder but the benefit-risk ratio was unclear as of 2005. It ...
... sleep disorders, intrinsic MeSH F03.870.400.800.200 - disorders of excessive somnolence MeSH F03.870.400.800.200.400 - ... panic disorder MeSH F03.080.725 - phobic disorders MeSH F03.080.931 - stress disorders, traumatic MeSH F03.080.931.249 - combat ... conduct disorder MeSH F03.550.300 - child behavior disorders MeSH F03.550.325 - child development disorders, pervasive MeSH ... reactive attachment disorder MeSH F03.550.787 - stereotypic movement disorder MeSH F03.550.825 - tic disorders MeSH F03.550. ...
These deaths, relatively soon after the drug's introduction, were said to be due to excessive doses given to shocked trauma ... Other side-effects include headache, agitated emergence, prolonged somnolence, and nausea. Intravenous administration of sodium ... a severe breathing disorder, or a family history of porphyria. Co-administration of pentoxifylline and thiopental causes death ...
It is used to treat schizophrenia, bipolar disorder, and irritability associated with autism. Common adverse effects of ... Excessive Salivation (oral, 1% to 10% ; IM, 1% to 4%) Increased appetite (oral, adult, more than 5%; pediatric, 4% to 47% ; IM ... Dyspnoea Asthenia Agitation Urinary incontinence Arthralgia Myalgia Epistaxis Somnolence (oral, adult, 3% to 6%; pediatric, 8% ... side effect of risperidone in combination with depakine chrono in a patient with bipolar disorder". Psychiatr Danub. 22 (1): ...
Excessive activation of PKC results in symptoms related to bipolar disorder. The PKC signaling pathway is a target for the ... Other side effects were: gastritis, epigastric discomfort, diarrhea, restlessness, somnolence, etc. Some of the adverse events ... protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder". Bipolar Disorders. 23 (6): 595- ... Bipolar disorder is associated with overactive protein kinase C (PKC) intracellular signaling. To date, there have been three ...
For panic disorder, gabapentin has produced mixed results. Gabapentin is effective in treating sleep disorders such as insomnia ... Dizziness and somnolence are the most frequent side effects. Fatigue, ataxia, peripheral edema (swelling of extremities), and ... Through excessive ingestion, accidental or otherwise, persons may experience overdose symptoms including drowsiness, sedation, ... anxiety disorders and bipolar disorder. There is concern regarding gabapentin's off-label use due to the lack of strong ...
Neurological disorders, Substance-related disorders, Syndromes affecting the gastrointestinal tract, Syndromes affecting the ... Bromide has an elimination half-life of 9 to 12 days, which can lead to excessive accumulation. Doses of 0.5 to 1 gram per day ... Bromism is caused by a neurotoxic effect on the brain which results in somnolence, psychosis, seizures, and delirium. Bromism ... Bromism was once a very common disorder, being responsible for 5 to 10% of psychiatric hospital admissions, but is now uncommon ...
Excessive appetite (hyperphagia) and unusual cravings are present in half to two thirds of cases. About half of patients, ... Patients with the syndrome are more likely than the general population to have genetic disorders, and about a third of people ... Neuropediatrics 2003;34:113-9 Levin, M. (1936). Periodic somnolence and morbid hunger: a new syndrome. Brain, 59(4), 494-504. ... In 1815, there was a report of a young man who showed excessive appetite and prolonged sleep after experiencing a fever; this ...
Learn about Disorders of Excessive Somnolence at online-medical-dictionary.org ... DOES (Disorders of Excessive Somnolence). DOESs (Disorders of Excessive Somnolence). Excessive Somnolence Disorder. Excessive ... Secondary Hypersomnolence Disorder. Secondary Hypersomnolence Disorders. Somnolence Disorder, Excessive. Somnolence Disorders, ... Hypersomnolence Disorder. Hypersomnolence Disorder, Primary. Hypersomnolence Disorder, Secondary. Hypersomnolence Disorders. ...
Get detailed information about the causes and management of the major sleep disorders in this summary for clinicians. ... Sleep disorders (e.g., insomnias, sleep apnea, hypersomnias, parasomnias, and problems with circadian rhythm) are common in ... Sleep-related breathing disorders (sleep apnea).. *Disorders of excessive somnolence (hypersomnias).. *Disorders of the sleep- ... It is indicated in the evaluation of suspected sleep-related breathing disorders and periodic limb movement disorder, when the ...
High risk for OSA and excessive daytime sleepiness is prevalent among the insulin-resistant subgroup of obese individuals. ... Disorders of Excessive Somnolence / epidemiology * Disorders of Excessive Somnolence / physiopathology * Female * Humans ... Conclusions: High risk for OSA and excessive daytime sleepiness is prevalent among the insulin-resistant subgroup of obese ... Purpose: Obstructive sleep apnea (OSA) is an increasingly common sleep disorder, especially among obese adults. Early ...
Disorders of Excessive Somnolence / diagnosis * Disorders of Excessive Somnolence / epidemiology* * Dopamine Agonists / ...
Sleep disorders are commonly underdiagnosed and are a significant source of concern in the geriatric population. Several ... assessment of excessive daytime somnolence) ... Fast Five Quiz: How Much Do You Know About Sleep Disorders? * ... Because of the variability of the presentation of the disorder, any or all symptoms of insomnia or other sleep disorders may ... encoded search term (Geriatric Sleep Disorder) and Geriatric Sleep Disorder What to Read Next on Medscape ...
Excessive daytime somnolence. This may be due to a sleep-related breathing disorder or narcolepsy. It causes episodes of loss ... Panic disorder. This may be associated with autonomic phenomena and anxiety similar to those observed in the simple partial ( ... Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol. 1996 Aug. 40(2):227-35. [QxMD MEDLINE Link] ... Migraine headache is another paroxsymal neruologic disorder that sometimes can be mistaken for seizures (and vice versa), as it ...
... encompasses a spectrum of disorders with implications in many fields of medicine. In its most recognizable and ubiquitous form ... Excessive daytime somnolence: This symptom is observed in 70% of patients. Motor vehicle accidents are a significant concern in ... For example, if a young, athletic male is experiencing excessive daytime somnolence and is receiving complaints from his bed ... Sleep-disordered breathing (SDB) encompasses a spectrum of disorders with implications in many fields of medicine. The spectrum ...
"Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: A case-control study". Sleep. 28 (6): 667- ... It should be used with extreme caution in people with bipolar disorder due to the potential induction of mania or hypomania. ... Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and addictive disorders". In Sydor A, Brown RY (eds.). ... de Sousa A, Kalra G (January 2012). "Drug therapy of attention deficit hyperactivity disorder: current trends". Mens Sana ...
Other sleep disorders. Patients with PD have many other sleep manifestations, including insomnia and excessive daytime ... somnolence.25 These abnormalities are due to degeneration in diffuse structures, which include pontine structures that ... REM sleep behaviour disorder. REM sleep behaviour disorder (RBD) is characterised by a loss of the normal atonia of REM sleep- ... Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Movement Disorders 2008;23:1665-72. ...
IntrinsicDisorders of Excessive SomnolenceNarcolepsyCataplexy. All MeSH CategoriesPsychiatry and Psychology CategoryMental ... DisordersSleep Wake DisordersDyssomniasSleep Disorders, IntrinsicDisorders of Excessive SomnolenceNarcolepsyCataplexy ... All MeSH CategoriesDiseases CategoryNervous System DiseasesSleep Wake DisordersDyssomniasSleep Disorders, ... The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or ...
REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3). Mov Disord. 2003 Dec; 18(12):1520-2. ... Association of Sleepwalking and REM Sleep Behavior Disorder With Parkinson Disease in Men. JAMA Netw Open. 2021 04 01; 4(4): ... Sleepwalking, REM sleep behaviour disorder and overlap parasomnia in patients with Parkinsons disease. Eur Neurol. 2013; 70(5- ... Sleep and movement disorders]. Ther Umsch. 2007 Jan; 64(1):63-72. ...
OSA causes severe symptoms, such as excessive daytime somnolence, and is associated with a significant cardiovascular morbidity ... A nocturnal breathing disorder - obstructive sleep apnea syndrome Trusted Source Obstructive sleep apnoea syndrome and its ... OSA causes severe symptoms, such as excessive daytime somnolence, and is associated with a significant cardiovascular morbidity ... Medicines for sleep disorders and anxiety contain active ingredients which may relax the muscles. This can therefore lead to ...
Excessive daytime somnolence (EDS) is defined as the inability to stay awake in daily life activities. Several scales have been ... used to diagnose excessive daytime sleepiness, the most widely used being the Epworth Sleepiness Scale (ESS). Sleep disorders ... Could a Virtual Human Be Used to Explore Excessive Daytime Sleepiness in Patients? Pierre Philip, Pierre Philip ... Could a Virtual Human Be Used to Explore Excessive Daytime Sleepiness in Patients?. Presence: Teleoperators and Virtual ...
Somnolence. Definition: A disorder characterized by characterized by excessive sleepiness and drowsiness. ... Synonyms (terms occurring on more labels are shown first): somnolence More information: PubMed search and possibly Wikipedia ...
The symptoms include excessive daytime somnolence and are associated with a significant cardiovascular morbidity and mortality ... Obstructive sleep apnea (OSA) is a common sleep disorder characterized by complete cessation of upper airflow during sleep, ...
... that have been associated with different clinical disorders and outcomes. These patterns offer unique research opportunities to ... identified by ORP architecture and the opportunities for research to advance management of sleep-disordered breathing, insomnia ... that have been associated with different clinical disorders and outcomes. These patterns offer unique research opportunities to ... identified by ORP architecture and the opportunities for research to advance management of sleep-disordered breathing, insomnia ...
... somnolence, speech disorder (e.g., stuttering, excessive speech), palpitation, twitching, dyspnea, sweating, dysmenorrhea, and ... Induction of a Manic Episode in Patients with Bipolar Disorder CNS stimulants may induce a manic or mixed episode in patients. ... ADZENYS XR-ODT has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, ... ADZENYS XR-ODT has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, ...
Excessive daytime. Uncommon. Very common. somnolence. Neurobehavioral. Hyperactivity, developmental delay. Cognitive impairment ... Excessive daytime sleepiness is common, and it has not been well established whether this is due entirely to sleep-disordered ... Although some respiratory disorders, such as sleep apnea, occur only during sleep, virtually all respiratory disorders- ... Waters KA, Forbes P, Morielli A, Hum C, OGorman AM, Vernet O, Davis GM, Tewfik TL, Ducharme FM, Brouillette RTSleep-disordered ...
Sleep Disordered Breathing Nursing and Health Professions 100% * Daytime Somnolence Nursing and Health Professions 100% ... Simpamba K, May JL, Waghat A, Attarian H, Mateyo K. Obstructive sleep apnea and excessive daytime sleepiness among commercial ... Simpamba, K., May, J. L., Waghat, A., Attarian, H., & Mateyo, K. (2023). Obstructive sleep apnea and excessive daytime ... Simpamba, K, May, JL, Waghat, A, Attarian, H & Mateyo, K 2023, Obstructive sleep apnea and excessive daytime sleepiness among ...
Levodopa is associated with somnolence and has been associated very rarely with excessive daytime somnolence and sudden sleep ... Impulse control disorders. Patients should be regula. rl. y monitored for the development of impulse control disorders. ... Levodopa is associated with somnolence and has been associated very rarely with excessive daytime somnolence and sudden sleep ... Levodopa-benserazide is associated with somnolence and has been associated very rarely with excessive daytime somnolence and ...
... excessive sleep or somnolence (hypersomnia), a sensation of heaviness in limbs known as leaden paralysis, and significant ... A mood disorder, also known as an affective disorder, is any of a group of conditions of mental and behavioral disorder[2] ... Depressive and related disorders and bipolar and related disorders. Bipolar disorders fall in between depressive disorders and ... Bipolar disorders Edit *Bipolar disorder (BD) (also called "manic depression" or "manic-depressive disorder"), an unstable ...
... including obstructive sleep apnea which results in excessive daytime somnolence, poor performance, increased frequency of road ... Bone Marrow Failure Disorder: Myelodysplastic Syndrome (MDS) is rare bone marrow failure disorder that increase risk of ... bipolar disorder, substance abuse, posttraumatic stress disorder, traumatic brain injury, and suicide. [106] [107] [108] [109] ... "Sleep Disorders in US Military Personnel: A High Rate of Comorbid Insomnia and Obstructive Sleep Apnea." Chest 144.2 (2013): ...
Sleep Disorders. Excessive Daytime Somnolence. Excessive Daytime Somnolence, also known as Excessive Daytime Sleepiness (EDS) ... Sleep/wake schedule disorder. This disorder causes Excessive Daytime Sleepiness and difficulty falling asleep and waking at ... Periodic Limb Movement Disorder. This disorder often occurs with other sleep disorders particularly Restless Leg Syndrome. An ... This leads to a neurological disorder. The patient will experience Excessive Daytime Sleepiness and may even uncontrollably ...
Disordered sleep, poor sleep quality, and insufficient or excessive sleep duration are known triggers of migraine and tension- ... and somnolence -- and were less likely to report sleep adequacy than episodic migraine patients. ... defined by International Classification of Headache Disorders-3 criteria. Participants had an average age of 35 and 88% were ...
A relatively rare sleep disorder characterized by acting out dreams during REM sleep -- often violently -- is closely linked to ... Somnolence And Excessive Daytime Sleepiness. Somnolence and EDS occur commonly in PD. Etiologies of somnolence in PD include ... Excessive Daytime Sleepiness In Pd. Excessive daytime sleepiness is a common symptom in PD and can occur anywhere from 15 to 21 ... REM Sleep Behaviour Disorder, Parkinsons and AI A relatively rare sleep disorder characterized by acting out dreams during REM ...
Consequences of untreated obstructive sleep apnea include failure to thrive, enuresis, attention-deficit disorder, behavior ... Obstructive sleep-disordered breathing is common in children. From 3 percent to 12 percent of children snore, while obstructive ... Compared with adults, fewer children with OSA report excessive daytime somnolence, with the notable exception of obese children ... Sleep-disordered breathing in children is a timely public health concern, given the increasing rates of obesity and ...
Dyskinesias, nausea, sleep disorders, dystonia, excessive dreaming, anorexia, muscle cramps, orthostatic complaints, somnolence ...
Sleep Wake Disorders 27% * Sleep 26% * Disorders of Excessive Somnolence 11% * European Union 9% ... International classification of sleep disorders. Thorpy, M., May 2 2017, Sleep Disorders Medicine: Basic Science, Technical ... Sleep-related movement disorders. Monderer, R., Anees, S., Wu, W. P. & Thorpy, M. J., Jan 1 2023, Encyclopedia of Sleep and ... Sleep Disorders. Thorpy, M. & Zhao, C. G., Jan 1 2022, Neuroscience in the 21st Century: From Basic to Clinical: Third Edition. ...
In Study 1 and Study 2, impulse control disorders occurred in 1% of patients treated with Ongentys 50 mg and in no patient who ... Patients may not perceive warning signs, such as excessive drowsiness, or they may report feeling alert immediately prior to ... Falling Asleep During Activities of Daily Living and Somnolence: Patients treated with dopaminergic medications and medications ... Impulse Control/Compulsive Disorders: Patients treated with Ongentys can experience intense urges to gamble, increased sexual ...
Keywords : sleep apnea syndrome; disorders of excessive somnolence; snoring; faculty of Odontology.. ... We evaluated the following variables: sex, snoring, excessive tiredness, stop breathing and restless sleep. Despite the Epworth ... there is a considerable percentage of professors with excessive sleepiness, probably resulting from overloading professional. ...

No FAQ available that match "disorders of excessive somnolence"

No images available that match "disorders of excessive somnolence"